Interferon alpha for the treatment of superficial bladder cancer.
Naitoh
J
J
UCLA Medical Center 90024-1782, USA.
Franklin
J
J
O'Donnell
M A
MA
Belldegrun
A S
AS
D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D015994:Incidence; D016898:Interferon-alpha / Q000627:therapeutic use*; D012008:Recurrence; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control
D016898:Interferon-alpha